• 제목/요약/키워드: malignant melanoma

검색결과 206건 처리시간 0.028초

구강내 편평상피세포암의 방사선치료 후 발생한 악성 흑색종 - 증례보고 및 문헌고찰 - (Radiation-Induced Malignant Melanoma Following Radiation Treatment for Squamous Cell Carcinoma of the Oral Cavity - A Case Report and Review of Literature -)

  • 신영주;양광모;서현숙
    • Radiation Oncology Journal
    • /
    • 제16권1호
    • /
    • pp.87-90
    • /
    • 1998
  • 구강내에서 발생하는 악성 흑색종은 비교적 드문 종양으로 원인에 대해서는 정확히 알려져 있지는 않으나 방사선치료 후에 발생된 양성 흑색종이 악성으로 전환된 보고가 있다. 본원에서 구강내 편평상피세포암으로 국소방사선치료 후 동일한 부위에 6년 후에 악성 흑색종이 발생하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Malignant Anal Sac Melanoma in a Dog

  • Ahn, Soo-Min;Cho, Kyoung-Oh;Kim, Sang-Ki;Jung, Dong-In;Yu, DoHyeon
    • 한국임상수의학회지
    • /
    • 제36권6호
    • /
    • pp.349-352
    • /
    • 2019
  • A five-year-old female Yorkshire Terrier dog presented with a perianal mass. Fine needle aspiration revealed that the mass comprised two different types of cells: hepatoid epithelial cells and melanin-containing melanocytes. Histopathological examination confirmed perianal gland adenoma with malignant melanoma. Evidence of metastasis was found on thoracic radiography with soft-tissue densities observed within the pulmonary parenchyma. The dog survived for three months after diagnosis of malignant melanoma. This report describes the clinical findings, diagnostics used, cytological and histopathological findings, and the potential prognosis for a dog diagnosed with malignant anal sac melanoma.

종격동에 발생한 악성 흑색종;1례 보고 (Malignant Melanoma Arising from the Mediastinum - A Case Report -)

  • 이석열
    • Journal of Chest Surgery
    • /
    • 제25권8호
    • /
    • pp.791-794
    • /
    • 1992
  • Authors experienced a case of malignant melanoma of the mediastinum, At the time of first visit to the hospital, the female patient, aged 48, and had chief complaints of right shoulder pain that was radiated to its forearm and right Horner`s syndrome. In chest X-ray and CT, extrapulmonary circumscribed mass in the right apicomedial aspect of mediastinum was found. She had no nevus and no melanoma on entire skin area. We excised the tumor and confirmed it as malignant melanoma by histopathology.

  • PDF

족부의 악성 흑색종 (Malignant Melanoma of the Foot)

  • 문성훈;박홍기
    • 대한족부족관절학회지
    • /
    • 제10권1호
    • /
    • pp.18-23
    • /
    • 2006
  • Purpose: We reviewed the clinical finding of malignant melanoma of the foot in korean because it's advanced stage and extended lesion at diagnosis. Materials and Methods: Retrospective study was enforced about the 11 cases who has diagnosed to malignant melanoma of the foot from February 1995 to March 2004. The mean follow up period was 61 months. In this study we used age, sex, site, depth, histology, clinical stage, precursor lesion, misdiagnosis, interval to diagnosis, survival time, survival. Results: Average age was 58 years and number of female was six. Common site of involvement were heel of plantar surface (6 cases) and subungual area (2 cases). Depths of involvement were 0.3 to 10 mm, most common histological type was acral lentiginous melanoma (7 cases), stage 5 according to classification of Clark were 5 cases and stage 2 or more according to clinical staging were 8 cases. precursor lesion were benign melanocytic nevi (2 cases) and ill defined (9 cases). Chief complaint were increasing of size, color change, pain and ulceration. Conclusion: Malignant melanoma of the foot usually arise at nonvisible area and is easy to be misdiagnosed or delayed treatment. So it is hard to early diagnosis and have poor prognosis. So we need education and effort to early detection and diagnosis.

  • PDF

Malignant melanoma on a thermal burn scar

  • Lee, Han Byul;Han, So Eun;Chang, Lan Sook;Lee, Soo Hyang
    • 대한두개안면성형외과학회지
    • /
    • 제20권1호
    • /
    • pp.58-61
    • /
    • 2019
  • Chronic burn scars often cause various skin malignancies at rates of up to 2%. These lesions are usually squamous cell carcinomas, but rarely, malignant melanoma is reported. We report a 67-year-old male with a malignant melanoma on a burn scar with regional metastasis. This patient presented an ulcerative lesion only in 2 weeks. After histopathological diagnosis, we performed only palliative surgery on patient's demand, and followed up the subsequent deterioration course. Our case reemphasizes the need for rapid diagnosis and treatment when suspect lesions are present on chronic burn scar. Also, physician should be in mind and inform the patient about malignant melanoma and its aggressive course.

Primary Malignant Melanoma in the Pineal Region

  • Park, Jae-Hyun;Hong, Yong-Kil
    • Journal of Korean Neurosurgical Society
    • /
    • 제56권6호
    • /
    • pp.504-508
    • /
    • 2014
  • A 59-year-old male patient had 5-month history of gait disturbance and memory impairment. His initial brain computed tomography scan showed $3.5{\times}2.8cm$ sized mass with high density in the pineal region. The tumor was hypointense on T2 weighted magnetic resonance images and hyperintense on T1 weighted magnetic resonance images with heterogenous enhancement of central portion. The tumor was totally removed via the occipital transtentorial approach. Black mass was observed in the operation field, and after surgery, histopathological examination confirmed the diagnosis of malignant melanoma. Whole spine magnetic resonance images and whole body 18-fluoro-deoxyglucose positron emission tomography could not demonstrate the primary site of this melanoma. Scrupulous physical examination of his skin and mucosa was done and dark pigmented lesion on his left leg was found, but additional studies including magnetic resonance images and skin biopsy showed negative finding. As a result, final diagnosis of primary pineal malignant melanoma was made. He underwent treatment with the whole brain radiotherapy and extended local boost irradiation without chemotherapy. His preoperative symptoms were disappeared, and no other specific neurological deficits were founded. His follow-up image studies showed no recurrence or distant metastasis until 26 weeks after surgery. Primary pineal malignant melanomas are extremely rare intracranial tumors, and only 17 cases have been reported since 1899. The most recent case report showed favorable outcome by subtotal tumor resection followed by whole brain and extended local irradiation without chemotherapy. Our case is another result to prove that total tumor resection with radiotherapy can be the current optimal treatment for primary malignant melanoma in the pineal region.

알러젠 제거 옻나무 추출물 투여로 호전된 악성흑색종(惡性黑色腫) 환자 1례 (A Case of Malignant Melanoma Patient Treated with Allergen-removed Rhus Verniciflua Stokes)

  • 정종수;김경석;박재우;정현식;윤성우
    • 대한한방내과학회지
    • /
    • 제28권3호
    • /
    • pp.655-661
    • /
    • 2007
  • Malignant melanoma is rare in Asians and one of the poorer prognostic diseases. Malignant melanoma accounts for only a small ratio of all skin cancers, but it causes the greatest number of skin cancer - related deaths worldwide. Melanoma incidence has continued to increase worldwide and in Korea, like other countries, the number of patients has increased compared with previous cancer incidence data. In this case report, we describe a case of a malignant melanoma patient who showed neck node metastasis (right supraclavicular area) after wide excision of facial melanoma 2 years before the diagnosis of relapse. The patient refused to get conventional western medical treatment including chemotherapy and the size of cancer increased over the 5 months of clinical follow-up. After 4 months of traditional Korean medical treatment using allergen-removed Rhus verniciflua Stokes(A-RVS), however, the size of cancer mass decreased and the patient showed no side effects. Further study will be needed in order to determine the long-term effect of allergen-removed Rhus verniciflua Stokes on patients with malignant melanoma.

  • PDF

소아의 원발성 악성 연수막 흑색종 - 증 례 보 고 - (Primary Malignant Leptomeningeal Melanoma in a Child - A Case Report -)

  • 손영제;왕규창;김연미;신상훈;지제근;조병규
    • Journal of Korean Neurosurgical Society
    • /
    • 제29권9호
    • /
    • pp.1243-1247
    • /
    • 2000
  • Primary malignant leptomeningeal melanoma is very rare, accounting for less than 0.1 percent of tumors in the central nervous system. Patients with primary intracranial malignant melanoma tend to be younger than metastatic intracranial melanoma, most commonly in the fourth decade of life. This tumor is extremely rare and the biologic behavior is aggressive especially in children. The authors report a case of primary malignant leptomeningeal melanoma in a twelve-year-old boy which was initially diagnosed as meningitis. On autopsy, associated extensive leptomeningeal melanosis was confirmed and believed to be the origin of the tumor. This case emphasizes the pattern of clinical presentation and the significance of leptomeningeal melanosis in primary leptomeningeal melanoma.

  • PDF

두경부에 발생한 점막형 악성흑색종에서 nm23의 발현양상 (Expression of nm23 in Mucosal Melanoma of the Head and Neck)

  • 최종욱;정근;민헌기;김용환;이승훈;최건
    • 대한두경부종양학회지
    • /
    • 제13권1호
    • /
    • pp.3-8
    • /
    • 1997
  • Malignant melanoma has a very poor prognosis compared to other cancers. There are no specific tumor markers other than clinical staging and depth of invasion to predict the prognosis of the malignant melanoma. The nm23 has been known to inhibit the metastasis of the malignant melanoma, some studies showed that it is highly expressed in the malignant melanoma cell line which has a relatively weak metastatic potential. In this study, we compared the expression of nm23 in mucosal type with that in cutaneous type of the malignant melanoma in the head and neck according to the stage and survival rate to identify the role of nm23 expression as a prognostic factor in mucosal melanoma of the head and neck. Six out of eight cases in mucosal type and seven out of 11 cases in cutaneous type expressed nm23, which showed no significant differences. Between the two groups there were no significant differences in expression of nm23 according to clinicopathologic staging or two year survival rate. However, in cases with low cliniopathological staging and those surviving more than two years the expression was significantly increased which suggests that expression of nm23 can be used as an aid in determining the prognosis of mucosal melanoma.

  • PDF

악성 피부 종양에서의 Fibroblast Growth Factor 4 (FGF4) 발현 (Fibroblast Growth Factor 4 (FGF4) Expression in Malignant Skin Cancers)

  • 조문균;송우진;김철한
    • Archives of Plastic Surgery
    • /
    • 제38권3호
    • /
    • pp.217-221
    • /
    • 2011
  • Purpose: FGF4 (fibroblast growth factor 4) is a newly characterized gene which was found to be a transforming gene in several cancerous cells. FGF4 expression and amplification has been subsequently observed in several human cancers including stomach cancer, breast cancer, head and neck squamous cell carcinoma, lung cancer and bladder cancer. This study was designed to measure the protein expression of FGF4 in malignant skin cancers. Methods: We examined 8 normal skin tissues and 24 malignant skin tumor tissues which were 8 malignant melanomas, 8 squamous cell carcinomas and 8 basal cell carcinomas. The specimens were analyzed for the protein expression of FGF4 using immunohistochemical staining. To evaluate the amount of expression of FGF4, the histochemical score (HSCORE) was used. Results: FGF4 was expressed more intensely in malignant melanoma, followed by SCC and BCC in immunohistochemistry. The average HSCORE was 0.01 for normal skin, 2.02 for malignant melanoma, 1.28 for squamous cell carcinoma, and 0.27 for basal cell carcinoma, respectively. The expression of FGF4 in malignant melanoma and squamous cell carcinoma was increased in comparison with normal tissues and basal cell cancer, and the difference was statistically significant (p<0.05). The difference between malignant melanoma and squamous cell carcinoma was not statistically significant. Conclusion: These findings provide evidences that the expression of FGF4 plays an important role in malignant melanoma and squamous cell carcinoma progressions. This article demonstrates expression of FGF4 in human skin malignant tumors, and suggests that FGF4 is more expressed in highly aggressive skin tumors.